Apolipoprotein E genotyping in patients with neurodegenerative diseases

Clinical Biochemistry

Volumn 30, Issue 5, 1997, Pages 405-411

  Ballering, Leo A P ^a   Steffens Nakken, Helga M ^a   Esselink, Rianne A J ^a   De Vos, Rob A I ^b   Jansen Steur, Ernst N H ^a   Vermes, Istvan ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b Laboratory for Pathology   (Netherlands)

Author keywords

Alzheimer's disease; Apolipoprotein E; Formalin fixed paraffin embedded brain tissue; Genotyping; Parkinson's disease; Semi nested PCR

Indexed keywords

APOLIPOPROTEIN E; BIOTIN; FORMALDEHYDE; OLIGONUCLEOTIDE; PARAFFIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEMENTIA; DNA HYBRIDIZATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE FIXATION;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; GENOTYPE; HUMANS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION;

EID: 0031194437     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00003-9     Document Type: Article

References (29)

1. 1. Corder EH, Saunders AM, Schmechel D et al. Gene dose of apolipoprotein E type-4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
2. 2. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci USA 1995; 92: 4725-7.
3. 3. Siest G, Pillot T, Régis-Bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-86.
4. 4. Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 1994; 344: 889.
5. 5. Lippa CF, Smith TW, Saunders AM, et al. Apolipoprotein E genotype and Lewy body disease. Neurology 1995; 45: 97-103.
6. 6. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia 1994; 5: 240-2.
7. 7. Warring SC, O'Brien PC, Kurland LT, et al. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/Parkinsonism-dementia complex. Lancet 1994; 343: 611.
8. 8. Amouyel P, Vidal O, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994; 344: 1315-18.
9. 9. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
10. 10. ACMG/ASHG working group on ApoE and Alzheimer's disease. Statement on the use of apolipoprotein E testing for Alzheimer's disease. JAMA 1995; 274: 1627-9.
11. 11. Kakulas BA, Vanbockxmeer FM. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995; 38: 966-7.
12. 12. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer's disease. Ann Neurol 1995; 38: 6-14.
13. 13. Richard P, Thomas G, Pascual de Zulueta M, et al. Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA. Clin Chem 1994; 40: 24-9.
14. 14. Prins J, Tilanus MGJ, van Rijn HJM. Apolipoproteïne E Genotypering. Tijdschr NVKC 1994; 19: 308-12. (in Dutch, English abstract)
15. 15. Weisgraber KH, Newhouse YM, Mahley RW. Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes. Biochem Biophys Res Comm 1988; 157: 1212-17.
16. 16. Tsai MY, Suess P, Schwichtenberg K, et al. Determination of apolipoprotein E genotypes by single strand conformational polymorphism. Clin Chem 1993; 39: 2121-4.
17. 17. Wenham PR, Newton CR, Price WH. Analysis of Apolipoprotein E genotypes by the amplification refractory mutation system. Clin Chem 1991; 37: 241-4.
18. 18. Emi M, Wu LL, Robertson MA, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3: 373-9.
19. 19. Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 1991; 95: 117-24.
20. 20. Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem 1991; 39: 351-4.
21. 21. Kösel S, Graeber MB. Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol 1994; 88: 19-25.
22. 22. Rogers BB, Alpert LC, Hine EAS, Buffone GJ. Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol 1990; 136: 541-8.
23. 23. Gall K, Pavelic J, Jadro-Santel D, Poljak M, Pavelic K. DNA amplification by polymerase chain reaction from brain tissues embedded in paraffin. Int J Exp Pathol 1993; 74: 333-7.
24. 24. Brenninkmeijer BJ, Stuyt PH, Demacker PN, Stalenhoef AF, van't Laar A. Hypertriglyceridemia and Apo E polymorphism (abstr). Arteriosclerosis 1986; 6: 546A.
25. 25. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993; 39: 2125-9.
26. 26. Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB. Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol 1995; 90: 257-65.
27. 27. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995; 37: 242-5.
28. 28. Arai H, Muratmatsu T, Higuchi S, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 1994; 344: 889.
29. 29. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.